Pedigree reconstruction using genetic analysis provides a useful means to estimate fundamental population biology parameters relating to population demography, trait heritability and individual fitness when combined with other sources of data.
These network approaches enable also the inclusion of clinical data from patients, which can comprise collected data during standard treatment procedures, and during clinical trials include histopathology, cancer stages and scores, prognosis (survival time, relapse time), cancer subtypes, and cancer biology parameters like ER-status for breast cancer [ 53].
Such Evolutionary Strategies have been implemented in systems biology parameter estimation tools [ 29], and in particular an adapted ES (the island-ES) has been shown to fit a gene network model more efficiently than Simulated Annealing [ 19].
This inclusion of the parameter uncertainties is important, because in systems biology the parameters are often undetermined [ 4], and an important continuation of this work will therefore be to compare the LHR with future extensions of the herein presented frequentist approaches to also include parameter uncertainty.
This is a crucial approach for model calibration in Systems Biology, where parameters are often spread over several orders of magnitude and systems can be observed only partially with relatively large measurement noise.
One of the challenging tasks in systems biology is parameter estimation in nonlinear dynamic models.
Evidently, many quite different sets of parameter values produce behaviors that resemble the reference model behavior, suggesting that the endocytosis modeling task, as many others in system biology, has parameter identifiability problems.
For all biology-epidemiology parameters, for example, ranges were expected to reflect what is known about the natural spread of smallpox, but existing information comes from efforts to treat, impede, and ultimately eradicate smallpox; the data were not collected to guide modelers, researchers, and policymakers.
This approach has been promoted and called "complex biology with no parameters" [4].
Although this approach has proved useful, it prevents the detailed species-by-species analysis that is needed to uncover the biology underlying species' parameters.
Secondary objectives encompassed TI on the combination of Aza+ESA, effect on bone marrow morphology and biology, peripheral blood parameters, cytogenetics, safety and response in relation to mutational status.
